CRYOPORT, INC. Number of Reportable Segments
CRYOPORT, INC. (CYRX) reported Number of Reportable Segments of 1 segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfReportableSegments · last filed 2026-08-06
- CRYOPORT, INC. number of reportable segments for the quarter ending 2026-03-31 was 1.00 segment, a 50.00% decline year-over-year.
- CRYOPORT, INC. number of reportable segments for the quarter ending 2025-03-31 was 2.00 segment, a 100.00% increase year-over-year.
- CRYOPORT, INC. number of reportable segments for the quarter ending 2024-12-31 was 2.00 segment.
- CRYOPORT, INC. number of reportable segments for the quarter ending 2024-03-31 was 1.00 segment, a 0.00% change year-over-year.
- CRYOPORT, INC. number of reportable segments for fiscal 2025 was 1.00 segment, a 50.00% decline from fiscal 2024.
- CRYOPORT, INC. number of reportable segments for fiscal 2024 was 2.00 segment.
- CRYOPORT, INC. number of reportable segments for fiscal 2022 was 2.00 segment, a 0.00% change from fiscal 2021.
- CRYOPORT, INC. number of reportable segments for fiscal 2021 was 2.00 segment, a 0.00% change from fiscal 2020.
segment
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.00 segment 10-Q · filed 2026-08-06 | |||
| 2026-03-31 | 1.00 segment 10-Q · filed 2026-05-05 | |||
| 2025-12-31 | 1.00 segment 10-K · filed 2026-03-05 | |||
| 2025-09-30 | 1.00 segment 10-Q · filed 2025-11-06 | |||
| 2025-03-31 | 2.00 segment 10-Q · filed 2025-05-08 | |||
| 2024-12-31 | 2.00 segment 10-K · filed 2025-03-07 | 2.00 segment 10-K · filed 2025-03-07 | ||
| 2024-09-30 | 1.00 segment 10-K · filed 2025-03-07 | |||
| 2024-06-30 | 1.00 segment 10-Q · filed 2024-08-08 | |||
| 2024-03-31 | 1.00 segment 10-Q · filed 2024-05-08 | |||
| 2023-09-30 | 1.00 segment 10-Q · filed 2023-11-09 | |||
| 2023-06-30 | 1.00 segment 10-Q · filed 2023-08-09 | |||
| 2023-03-31 | 1.00 segment 10-Q · filed 2023-05-04 | |||
| 2022-12-31 | 2.00 segment 10-K · filed 2023-02-28 | |||
| 2022-09-30 | 1.00 segment 10-Q · filed 2022-11-04 | |||
| 2022-06-30 | 1.00 segment 10-Q · filed 2022-08-04 | |||
| 2021-12-31 | 2.00 segment 10-K · filed 2022-02-28 | |||
| 2020-12-31 | 2.00 segment 10-K · filed 2021-03-01 | |||
| 2020-09-30 | 2.00 segment 10-Q · filed 2020-11-06 | |||
| 2020-06-30 | 2.00 segment 10-Q · filed 2020-08-10 | |||
| 2020-03-31 | 2.00 segment 10-Q · filed 2020-05-08 | |||
| 2019-12-31 | 2.00 segment 10-K · filed 2020-03-10 | |||
| 2019-09-30 | 2.00 segment 10-Q · filed 2019-11-12 | |||
| 2019-06-30 | 2.00 segment 10-Q · filed 2019-08-09 |
USD
| Period end | Number of Reportable Segments 12 month |
|---|---|
| 2023-12-31 | $1.00 10-K · filed 2024-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |